Cellular and Molecular Mechanisms of Retinal Ganglion Cell Death in Hypoxic-Ischemic Injuries
Journal Title: Journal of Neurology and Experimental Neuroscience - Year 2015, Vol 1, Issue 1
Abstract
Loss of retinal ganglion cells (RGCs) occurs in retinal degenerative diseases, such as glaucoma, age-related macular degeneration, diabetic retinopathy, central retinal artery occlusion and ischemic central retinal vein thrombosis in adults and in retinopathy of prematurity in infants. A critical role of hypoxia, which underlies most of the above disorders, has been reported in causing RGC death. Disruption of blood-retinal barrier (BRB) occurs due to increased production of vascular endothelial growth factor and nitric oxide in response to hypoxia resulting in extravasation of serum derived substances and retinal edema and this may be one of important factors mediating RGC death. Activation of microglial cells in response to hypoxia and subsequent increased release of proinflammatory cytokines by them such as tumor-necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) target the TNF-receptor 1 and IL-receptor 1 on RGCs. Excess release of glutamate in retinal tissue under hypoxia activates the ionotropic glutamate receptors causing excitotoxicity through increased influx of calcium into the RGCs. Increased production of TNF-α, IL-1β and enhanced intracellular calcium results in RGC death through activating several pathways such as caspase signaling, mitochondrial dysfunction and oxidative stress. In our investigations, melatonin, an antioxidant, was shown to reduce RGC death in the adult and neonatal hypoxic retina, through suppression of TNF-α, IL-1β and glutamate levels as well as oxidative stress. Moreover, the function and structure of BRB was well preserved in these animals along with reduction in retinal edema. In view of our observations, we suggest that melatonin could be considered as a therapeutic agent to reduce RGC death in various retinal pathologies, in addition to other potential drugs/molecules of therapeutic interest that could render protection to RGCs. However, future in-depth research on the effects of melatonin on the retina under hypoxic conditions needs to be undertaken to explore its full potential in preventing/ameliorating RGC death.
Juvenile Parkinsonism – A Diagnostic Dilemma
Parkinson’s disease (PD) is typically characterized by resting tremor, rigidity and bradykinesia with onset after 50 years of age. However sometimes, especially Juvenile Parkinsonism, may present with atypical features w...
Report on the Third Neurological Disorders Summit (NDS-2017)
The 3rd Neurological Disorders Summit (NDS-2017) organized by United Scientific Group was held from July 7, 2017 to July 9, 2017 at Crowne Plaza Hotel, San Francisco, USA. One hundred thirty five attendees from more than...
Neuropsychiatric Systemic Lupus Erythematosus: Making the Case for an Expanded Psychiatric Role
Systemic Lupus Erythematous can present with psychiatric symptoms. As these symptoms are non-specific and may occur in the absence of clear systemic signs and symptoms of lupus, they are difficult to distinguish from pri...
Recognition of Epileptiform K-Complexes in Generalized Epilepsy: A Case Report
Background: Epileptiform K-complex is spike/polyspike discharges overlap K-complex. The variable appearance of the K-complex makes the epileptiform abnormality difficult to recognize. Objective: To recognize and raise at...
Acute Psychosis and Epileptic Encephalopathy as a Preliminary Symptom Leading to the Diagnosis of Tuberous Sclerosis Complex in an Adolescent
Introduction: Tuberous sclerosis complex (TSC) is an autosomal dominant, variably expressed multisystemic disease. TSC-associated neuropsychiatric disorders (TAND) present at multilevel, and probably are underestimated i...